E-ISSN: 1308-5263
Comment: In Response to CD9 Is a Very Helpful Marker for Discriminating AML-M3 from HLA-DR-Negative Non-M3 AML [Turk J Hematol]
Turk J Hematol. 2020; 37(4): 289-290 | DOI: 10.4274/tjh.galenos.2020.2020.0572  

Comment: In Response to CD9 Is a Very Helpful Marker for Discriminating AML-M3 from HLA-DR-Negative Non-M3 AML

Smeeta Gajendra
Laboratory Oncology Unit, Dr. B.R.A. IRCH, AIIMS, New Delhi, India

Keywords: Acute promyelocytic leukemia, Flow cytometry, CD9, CD18


Yorum: CD9 AML-M3 HLA-DR Negatif M3 D AMLden Ayrt Etmede ok Faydal Bir Belirtetir

Smeeta Gajendra
Laboratory Oncology Unit, Dr. B.R.A. IRCH, AIIMS, New Delhi, India

Anahtar Kelimeler: Akut promiyelositik lsemi, Ak sitometrisi, CD9, CD18


Smeeta Gajendra. Comment: In Response to CD9 Is a Very Helpful Marker for Discriminating AML-M3 from HLA-DR-Negative Non-M3 AML. Turk J Hematol. 2020; 37(4): 289-290

Corresponding Author: Smeeta Gajendra, India


TOOLS
Full Text PDF
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share
Send email to author

Similar articles
PubMed
Google Scholar


 



Impact Factor (2019) = 1.685